Zobrazeno 1 - 10
of 95
pro vyhledávání: '"Peter A Sieling"'
Autor:
Shahrooz Rabizadeh, Kayvan R Niazi, Peter A Sieling, Steve Benz, Justin Golovato, Aleece Nolasco
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/6a2da5cf7bce4818aafdd6fe46294a10
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/ab2111d0b8dd47349a623eaf45cfa637
Autor:
Caiyun Xuan, Jaime M Shamonki, Alice Chung, Maggie L Dinome, Maureen Chung, Peter A Sieling, Delphine J Lee
Publikováno v:
PLoS ONE, Vol 9, Iss 1, p e83744 (2014)
Breast cancer affects one in eight women in their lifetime. Though diet, age and genetic predisposition are established risk factors, the majority of breast cancers have unknown etiology. The human microbiota refers to the collection of microbes inha
Externí odkaz:
https://doaj.org/article/d84ba8bffe4343799788665adccf17bd
Autor:
Mohit Verma, Shiho Tanaka, Lise Zakin, Kyle Dinkins, Adrian Rice, Wendy Higashide, Elizabeth R Gabitzsch, Peter A. Sieling, Emily A. Voigt, C. Anders Olson, Peter Battisti, Jeffrey T. Safrit, Corey Casper, Brett Morimoto, Sierra Reed, Patricia Spilman, Shivani Mody, Patrick Soon-Shiong, Sam Beaver
We assessed if immune responses are enhanced in CD-1 mice by heterologous vaccination with two different nucleic acid-based COVID-19 vaccines: a next-generation human adenovirus serotype 5 (hAd5)-vectored dual-antigen spike (S) and nucleocapsid (N) v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7f1e3a215501e9ac14c95d63c8e7af2b
https://doi.org/10.1101/2021.11.29.470440
https://doi.org/10.1101/2021.11.29.470440
Autor:
Jeff Drew, Raymond C.B. Wong, Brett Morimoto, Shahrooz Rabizadeh, Peter A. Sieling, Lennie Sender, Pete Bone, Daniel C. Sanford, Patrick Soon-Shiong, Andrew Bacon, Victor Peykov, Patricia Spilman, Adrian Rice, Jeffrey T. Safrit, Mohit Verma, Lise Zakin, Joseph P. Balint, Kyle Dinkins, Hermes Garban, Ashish Bezawada, Kayvan Niazi, Annie Shin, Philip T. Liu, Helty Adisetiyo, Elizabeth Gabitzsch
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Frontiers in Immunology
Frontiers in Immunology
We have developed a dual-antigen COVID-19 vaccine incorporating genes for a modified SARS-CoV-2 spike protein (S-Fusion) and the viral nucleocapsid (N) protein with an Enhanced T-cell Stimulation Domain (N-ETSD) to increase the potential for MHC clas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90bfb1b5f44804ea2d0700d7392355e8
https://www.frontiersin.org/articles/10.3389/fimmu.2021.729837/full
https://www.frontiersin.org/articles/10.3389/fimmu.2021.729837/full
Autor:
Shivani Mody, Patricia Spilman, Kyle Dinkins, Kayvan Niazi, Annie Shin, Adrian Rice, Brett Morimoto, Helty Adisetiyo, Lise Zakin, Jeffrey T. Safrit, Shiho Tanaka, Shahrooz Rabizadeh, Elizabeth Gabitzsch, Peter A. Sieling, Joseph P. Balint, C. Anders Olson, Wendy Higashide, Patrick Soon-Shiong, Mohit Verma
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-15 (2021)
Scientific Reports
Scientific Reports
We have developed a COVID-19 vaccine, hAd5 S-Fusion + N-ETSD, that expresses SARS-CoV-2 spike (S) and nucleocapsid (N) proteins with modifications to increase immune responses delivered using a human adenovirus serotype 5 (hAd5) platform. Here, we de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5188699ef2a3eb832f85b5da86efcbde
https://doi.org/10.1038/s41598-021-94364-5
https://doi.org/10.1038/s41598-021-94364-5
Autor:
Anna M. Leung, Agnes Fermin Lee, Junko eOzao-Choy, Romela Irene Ramos, Omid eHamid, Steven J. O'Day, Myung eShin-Sim, Donald L. Morton, Mark B. Faries, Peter A. Sieling, Delphine J Lee
Publikováno v:
Frontiers in Oncology, Vol 4 (2014)
Stage IV metastatic melanoma patients historically have a poor prognosis with 5-10% 5-year survival. Ipilimumab, a monoclonal antibody against cytotoxic T-lymphocyte antigen 4 (CTLA4), is one of the first treatments to provide beneficial durable resp
Externí odkaz:
https://doaj.org/article/f38a13bb96e14ad0886b8e5acf0e9c61
Autor:
Thang L. Nguyen, Sixto Marcos, Pei-Yu Chiou, Shahrooz Rabizadeh, Alexander N. Patananan, Adam Lazar, Jon T. Van Lew, Noe Rodriguez, Luis Cisneros, Peter A. Sieling, Daniel Braas, Fasih M. Ahsan, Charles J. Vaske, Michael A. Teitell, Amy R. Vandiver, Amanda J. Collier, Artin Mehrabi, Alexander J. Sercel, Stephanie A.L. Kennedy, Lise Zakin, Emma R. Dawson, Tadros Wael, Alejandro Torres, Kayvan Niazi, Ting-Hsiang Wu, Justin Golovato, Kathrin Plath
Publikováno v:
Cell reports, vol 33, iss 13
Cell reports
Cell reports
SUMMARY Generating mammalian cells with desired mitochondrial DNA (mtDNA) sequences is enabling for studies of mitochondria, disease modeling, and potential regenerative therapies. MitoPunch, a high-throughput mitochondrial transfer device, produces
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3be74657fb561a48381afb40523ea40b
https://escholarship.org/uc/item/9xs7544n
https://escholarship.org/uc/item/9xs7544n
Autor:
Helty Adisetiyo, Justin Taft, Lennie Sender, Marta Martín-Fernández, Sofija Buta, Kayvan Niazi, Elizabeth Gabitzsch, Peter A. Sieling, Philip T. Liu, Roosheel S. Patel, Adrian Rice, Lise Zakin, Patricia Spilman, Annie Shin, Shahrooz Rabizadeh, Hermes Garban, Jeffrey T. Safrit, Brett Morimoto, Dusan Bogunovic, Patrick Soon-Shiong
To address the need for a safe, efficacious vaccine against SARS-CoV-2 infection with the critical properties of enabling both blocking viral entry into cells and clearing virus from cells already infected, we have developed a bivalent, human adenovi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ca8b60d0f264831585871b1076cbb46d
https://doi.org/10.1101/2020.11.04.20225417
https://doi.org/10.1101/2020.11.04.20225417
Autor:
Brett Morimoto, Sofija Buta, Justin Taft, Patrick Soon-Shiong, Kayvan Niazi, Shahrooz Rabizadeh, Marta Martín-Fernández, Patricia Spilman, Peter A. Sieling, Helty Adisetiyo, Elizabeth Gabitzsch, Annie Shin, Jeffrey T. Safrit, Rosheel Patel, Adrian Rice, Joseph P. Balint, Shiho Tanaka, Dusan Bogunovic, Kyle Dinkins, Mohit Verma, Lise Zakin
In response to the health crisis presented by the COVID-19 pandemic, rapid development of safe and effective vaccines that elicit durable immune responses is imperative. Recent reports have raised the concern that antibodies in COVID-19 convalescent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e93513b558e65bea7cf968653ef9af0c
https://doi.org/10.1101/2020.07.29.227595
https://doi.org/10.1101/2020.07.29.227595